Otros idiomas Vaxxinity, Inc.

Acciones

VAXX

US92244V1044

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,1166 ^USD	-3,95 %		-75,51 %	-86,28 %

27/03	Vaxxinity, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
07/03	Vaxxinity anuncia en AD/PD? datos positivos de compromiso de objetivos del ensayo clínico de fase 1 para la enfermedad de Parkinson 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Sector Update: Health Care Stocks Advance Premarket Monday	22/04
Sector Update: Health Care	22/04
Vaxxinity Issues Shareholder Letter	20/04
Vaxxinity Issues Shareholder Letter	20/04
Vaxxinity to Voluntarily Delist From Nasdaq; Shares Sink After Hours	19/04
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock	19/04
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting	28/03
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates	27/03
Vaxxinity, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Vaxxinity : UB-312 Target Engagement - ADPD 2024	12/03
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024	07/03
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson?s Disease at AD/PD? 2024	07/03
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published	15/02
Vaxxinity, Inc. Announces the Publication of Data from Multiple Non-Human Primate Studies	15/02
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	13/02
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	13/02
Vaxxinity, Inc. to Present Data from UB-312 Program in Parkinson's Disease at International Conference on Alzheimer's and Parkinson's Diseases and Related Neurolog Disorders	13/02
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	30/01
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	30/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Vaxxinity, Inc.

Acciones

VAXX

US92244V1044

Otros idiomas

Filtros